X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
4-aminopyridine (142) 142
4‐aminopyridine (132) 132
animals (126) 126
4-aminopyridine - pharmacology (77) 77
male (76) 76
rats (74) 74
in vitro techniques (49) 49
neurosciences (44) 44
pharmacology & pharmacy (36) 36
4- aminopyridine (30) 30
index medicus (29) 29
potassium channels (28) 28
female (26) 26
biochemistry & molecular biology (25) 25
clinical neurology (25) 25
humans (25) 25
potassium channels - drug effects (25) 25
rats, wistar (24) 24
action potentials - drug effects (22) 22
tetraethylammonium (22) 22
4 aminopyridine (20) 20
dose-response relationship, drug (20) 20
epilepsy (20) 20
physiology (20) 20
potassium channel blockers (20) 20
aminopyridines - pharmacology (18) 18
disease models, animal (18) 18
electrophysiology (18) 18
patch-clamp techniques (18) 18
potassium channels - physiology (18) 18
rats, sprague-dawley (18) 18
electric stimulation (17) 17
hippocampus - drug effects (17) 17
membrane potentials - drug effects (17) 17
mice (17) 17
rat (17) 17
calcium - metabolism (15) 15
cells (15) 15
guinea pigs (15) 15
seizures (15) 15
potassium channel blockers - pharmacology (14) 14
calcium (13) 13
channels (13) 13
epilepsy - chemically induced (13) 13
hippocampus (13) 13
multiple sclerosis (13) 13
rats, inbred strains (13) 13
epileptiform activity (12) 12
potassium (12) 12
potassium - pharmacology (12) 12
synaptic transmission - drug effects (12) 12
tetraethylammonium compounds - pharmacology (12) 12
hippocampus - metabolism (11) 11
muscle contraction - drug effects (11) 11
seizures - chemically induced (11) 11
hippocampus - physiopathology (10) 10
k+ channels (10) 10
double-blind (9) 9
entorhinal cortex (9) 9
epilepsy - physiopathology (9) 9
fampridine (9) 9
neurons (9) 9
neurons - physiology (9) 9
papers (9) 9
time factors (9) 9
action potential (8) 8
action potentials - physiology (8) 8
gaba (8) 8
hippocampal slices (8) 8
iberiotoxin (8) 8
invitro (8) 8
membrane potentials - physiology (8) 8
neurons - drug effects (8) 8
potassium channels - metabolism (8) 8
seizures - physiopathology (8) 8
synaptosomes - metabolism (8) 8
4-aminopyridine - therapeutic use (7) 7
anticonvulsants - pharmacology (7) 7
calcium - physiology (7) 7
cardiac & cardiovascular systems (7) 7
charybdotoxin (7) 7
currents (7) 7
electroencephalography (7) 7
in-vitro (7) 7
kinetics (7) 7
middle aged (7) 7
rabbits (7) 7
seizure (7) 7
tetrodotoxin - pharmacology (7) 7
acetylcholine (6) 6
action potentials (6) 6
activation (6) 6
adult (6) 6
apamin (6) 6
article (6) 6
baclofen (6) 6
brain (6) 6
cerebral cortex - metabolism (6) 6
conductance (6) 6
cortex (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hippocampus, ISSN 1050-9631, 12/2019, Volume 29, Issue 12, pp. 1150 - 1164
Accumulation of amyloid‐beta (Aβ) in temporal lobe structures, including the hippocampus, is related to a variety of Alzheimer's disease symptoms and seems to... 
4‐aminopyridine | seizures | oscillations | amyloid beta | synaptic coupling | Temporal lobe | Neurodegenerative diseases | Epilepsy | Cognitive ability | Injection | Latency | Convulsions & seizures | Neural networks | Amyloidosis | Alzheimers disease | Alzheimer's disease | Hippocampus | Seizures
Journal Article
Epilepsia, ISSN 0013-9580, 12/2018, Volume 59, Issue 12, pp. 2219 - 2230
Summary Objective Low‐frequency fiber‐tract stimulation has been shown to be effective in treating mesial temporal lobe epilepsies through activation of the... 
4‐aminopyridine | neocortex | hippocampus | deep brain stimulation | primary motor cortex | 4-aminopyridine | DECREASES | CLINICAL NEUROLOGY | ANTERIOR NUCLEUS | WAXHOLM SPACE ATLAS | REDUCTION | ELECTRICAL-STIMULATION | THALAMUS | EPILEPTIFORM ACTIVITY | EPILEPSY | BRAIN | AMYGDALA | Epilepsy | Models | Seizures (Medicine)
Journal Article
Epilepsia, ISSN 0013-9580, 03/2019, Volume 60, Issue 3, pp. 464 - 474
Summary Objective The high incidence of epileptic seizures in neonates and their frequent refractoriness to pharmacologic therapies require identification of... 
4‐aminopyridine | in vitro epilepsy model | seizure | low Mg2 | CA3 | field‐potential recording | Taurine | Brain | Anticonvulsants | Analysis | Epilepsy | GABA | Mice | Seizures (Medicine) | Neonates | Firing pattern | γ-Aminobutyric acid A receptors | Muscimol | γ-Aminobutyric acid | Pentobarbital | Rodents | Strychnine | Magnesium | Hippocampus | Binding sites | Seizures
Journal Article
Fundamental & Clinical Pharmacology, ISSN 0767-3981, 02/2019, Volume 33, Issue 1, pp. 127 - 129
4‐Aminopyridine (4‐AP) is a recent treatment indicated to improve walking in patient with multiple sclerosis. We report the first case of pulmonary arterial... 
4‐aminopyridine | drug induced | multiple sclerosis | pulmonary hypertension | 4-aminopyridine | AMINOREX | PHARMACOLOGY & PHARMACY | SMOOTH-MUSCLE-CELLS | CHANNELS | Hypertension | Multiple sclerosis | Dyspnea | Catheterization | Etiology | Pulmonary arteries | Blood pressure | Pharmacology | Respiration | Potassium | Patients | Pulmonary artery
Journal Article
STEM CELLS, ISSN 1066-5099, 06/2016, Volume 34, Issue 6, pp. 1563 - 1575
Journal Article
Journal Article
Neurology, ISSN 0028-3878, 10/2014, Volume 83, Issue 18, pp. 1610 - 1612
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 09/2014, Volume 130, Issue 6, pp. 770 - 779
Journal Article